• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of eidLink to Publisher's site
Emerg Infect Dis. 1998 Apr-Jun; 4(2): 221–227.
PMCID: PMC2640135

Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

Abstract

In the past 2 decades, Burkholderia cepacia has emerged as a human pathogen causing numerous outbreaks, particularly among cystic fibrosis (CF) patients. One highly transmissible strain has spread across North America and Britain, and another between hospitalized CF and non-CF patients. Meanwhile, the organism has been developed as a biopesticide for protecting crops against fungal diseases and has potential as a bioremediation agent for breaking down recalcitrant herbicides and pesticides. However, B. cepacia is inherently resistant to multiple antibiotics; selection of strains "safe" for environmental application is not at present possible phenotypically or genotypically; molecular epidemiology and phylogenetic studies demonstrate that highly transmissible strains emerge randomly; and the organism has a capacity for rapid mutation and adaptation (facilitated by numerous insertion sequences), and a large, complex genome divided into separate chromosomes. Therefore, the widespread agricultural use of B. cepacia should be approached with caution.

Full Text

The Full Text of this article is available as a PDF (331K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Goldmann DA, Klinger JD. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr. 1986 May;108(5 Pt 2):806–812. [PubMed]
  • Thomassen MJ, Demko CA, Klinger JD, Stern RC. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis. 1985 May;131(5):791–796. [PubMed]
  • Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996 Sep;60(3):539–574. [PMC free article] [PubMed]
  • Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. [PubMed]
  • Tablan OC, Chorba TL, Schidlow DV, White JW, Hardy KA, Gilligan PH, Morgan WM, Carson LA, Martone WJ, Jason JM, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985 Sep;107(3):382–387. [PubMed]
  • Thomassen MJ, Demko CA, Doershuk CF, Stern RC, Klinger JD. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis. 1986 Oct;134(4):669–671. [PubMed]
  • Tablan OC, Martone WJ, Doershuk CF, Stern RC, Thomassen MJ, Klinger JD, White JW, Carson LA, Jarvis WR. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest. 1987 Apr;91(4):527–532. [PubMed]
  • Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol. 1996 May 15;143(10):1007–1017. [PubMed]
  • Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Jul 3;342(8862):15–19. [PubMed]
  • Walters S, Smith EG. Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications. Lancet. 1993 Jul 3;342(8862):3–4. [PubMed]
  • LiPuma JJ, Mortensen JE, Dasen SE, Edlind TD, Schidlow DV, Burns JL, Stull TL. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr. 1988 Nov;113(5):859–862. [PubMed]
  • Johnson WM, Tyler SD, Rozee KR. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol. 1994 Apr;32(4):924–930. [PMC free article] [PubMed]
  • Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol. 1997 Apr;35(4):808–816. [PMC free article] [PubMed]
  • Sun L, Jiang RZ, Steinbach S, Holmes A, Campanelli C, Forstner J, Sajjan U, Tan Y, Riley M, Goldstein R. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med. 1995 Jul;1(7):661–666. [PubMed]
  • Pitt TL, Kaufmann ME, Patel PS, Benge LC, Gaskin S, Livermore DM. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol. 1996 Mar;44(3):203–210. [PubMed]
  • Segonds C, Bingen E, Couetdic G, Mathy S, Brahimi N, Marty N, Plesiat P, Michel-Briand Y, Chabanon G. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol. 1997 Aug;35(8):2055–2060. [PMC free article] [PubMed]
  • Steinbach S, Sun L, Jiang RZ, Flume P, Gilligan P, Egan TM, Goldstein R. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med. 1994 Oct 13;331(15):981–987. [PubMed]
  • Ryley HC, Ojeniyi B, Høiby N, Weeks J. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 1996 Sep;15(9):755–758. [PubMed]
  • Govan JR, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 1996 Dec;45(6):395–407. [PubMed]
  • Taplin D, Bassett DC, Mertz PM. Foot lesions associated with Pseudomonas cepacia. Lancet. 1971 Sep 11;2(7724):568–571. [PubMed]
  • Jarvis WR, Olson D, Tablan O, Martone WJ. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol. 1987 Sep;3(3):233–236. [PubMed]
  • Anderson DJ, Kuhns JS, Vasil ML, Gerding DN, Janoff EN. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol. 1991 Mar;29(3):648–649. [PMC free article] [PubMed]
  • Pegues DA, Carson LA, Anderson RL, Norgard MJ, Argent TA, Jarvis WR, Woernle CH. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis. 1993 Mar;16(3):407–411. [PubMed]
  • Dixon RE, Kaslow RA, Mackel DC, Fulkerson CC, Mallison GF. Aqueous quaternary ammonium antiseptics and disinfectants. Use and misuse. JAMA. 1976 Nov 22;236(21):2415–2417. [PubMed]
  • Sobel JD, Hashman N, Reinherz G, Merzbach D. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med. 1982 Aug;73(2):183–186. [PubMed]
  • Hyde J, Humphreys H. Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 1997 Mar;16(3):253–254. [PubMed]
  • Tablan OC, Chorba TL, Schidlow DV, White JW, Hardy KA, Gilligan PH, Morgan WM, Carson LA, Martone WJ, Jason JM, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985 Sep;107(3):382–387. [PubMed]
  • Carson LA, Tablan OC, Cusick LB, Jarvis WR, Favero MS, Bland LA. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol. 1988 Oct;26(10):2096–2100. [PMC free article] [PubMed]
  • Gilligan PH, Gage PA, Bradshaw LM, Schidlow DV, DeCicco BT. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1985 Jul;22(1):5–8. [PMC free article] [PubMed]
  • McLoughlin TJ, Quinn JP, Bettermann A, Bookland R. Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling the disease. Appl Environ Microbiol. 1992 May;58(5):1760–1763. [PMC free article] [PubMed]
  • Sangodkar UM, Chapman PJ, Chakrabarty AM. Cloning, physical mapping and expression of chromosomal genes specifying degradation of the herbicide 2,4,5-T by Pseudomonas cepacia AC1100. Gene. 1988 Nov 30;71(2):267–277. [PubMed]
  • Tabacchioni S, Visca P, Chiarini L, Bevivino A, Di Serio C, Fancelli S, Fani R. Molecular characterization of rhizosphere and clinical isolates of Burkholderia cepacia. Res Microbiol. 1995 Sep;146(7):531–542. [PubMed]
  • Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, Revets H, Lauwers S, Gillis M, Kersters K, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol. 1997 Oct;47(4):1188–1200. [PubMed]
  • Cheng HP, Lessie TG. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol. 1994 Jul;176(13):4034–4042. [PMC free article] [PubMed]
  • Allardet-Servent A, Michaux-Charachon S, Jumas-Bilak E, Karayan L, Ramuz M. Presence of one linear and one circular chromosome in the Agrobacterium tumefaciens C58 genome. J Bacteriol. 1993 Dec;175(24):7869–7874. [PMC free article] [PubMed]
  • Suwanto A, Kaplan S. Physical and genetic mapping of the Rhodobacter sphaeroides 2.4.1 genome: genome size, fragment identification, and gene localization. J Bacteriol. 1989 Nov;171(11):5840–5849. [PMC free article] [PubMed]
  • Michaux S, Paillisson J, Carles-Nurit MJ, Bourg G, Allardet-Servent A, Ramuz M. Presence of two independent chromosomes in the Brucella melitensis 16M genome. J Bacteriol. 1993 Feb;175(3):701–705. [PMC free article] [PubMed]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...